AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33189627 — intervention group
Group type: COMPARATOR
Intervention: Control group (Amlodipine and Doxazosin)
Number of subjects: 27918
Study 33462940 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 20
Study 33462940 — intervention group
Group type: COMPARATOR
Intervention: Conventional pharmacological treatment (Essentiale plus Yasmin)
Number of subjects: 20
Study 32152377 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood diagnosis (CD) subjects
Number of subjects: 1442
Study 32152377 — intervention group
Group type: COMPARATOR
Intervention: Placebo-treated CD subjects
Number of subjects: 1442
Study 32152377 — intervention group
Group type: EXPERIMENTAL
Intervention: CD subjects
Number of subjects: 1442
Study 35715740 — intervention group
Group type: EXPERIMENTAL
Intervention: SDM-assistant
Number of subjects: 252
Study 35715740 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 252
Study 32744056 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of aspirin therapy during the perioperative period (33 eyes)
Number of subjects: 67
Study 32744056 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of aspirin therapy for 3 to 7 days before surgery (34 eyes)
Number of subjects: 67
Study 32744056 — intervention group
Group type: COMPARATOR
Intervention: Control group with no antiplatelet/anticoagulant therapy (43 eyes)
Number of subjects: 67
Study 36280113 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin treatment for 5 weeks
Number of subjects: 26
Study 32562450 — intervention group
Group type: EXPERIMENTAL
Intervention: Smectite at 0.5 g/kg PO per day divided in two to three doses
Number of subjects: 60
Study 32562450 — intervention group
Group type: COMPARATOR
Intervention: Control group without initial medication
Number of subjects: 60
Study 32562450 — intervention group
Group type: EXPERIMENTAL
Intervention: Smectite group
Number of subjects: 60
Study 33220069 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.03% ointment
Number of subjects: 40
Study 33220069 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide 0.1% cream
Number of subjects: 40
Study 32570515 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who received automatic interpretations of laboratory tests
Number of subjects: 3200
Study 32570515 — intervention group
Group type: COMPARATOR
Intervention: Patients who did not receive automatic interpretations of laboratory tests
Number of subjects: 3200
Study 35834790 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (nivolumab + ipilimumab)
Number of subjects: 79
Study 35834790 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab monotherapy
Number of subjects: 79
Study 34416347 — intervention group
Group type: EXPERIMENTAL
Intervention: SCP-NF (slow cortical potential neurofeedback)
Number of subjects: 103
Study 34416347 — intervention group
Group type: COMPARATOR
Intervention: Semi-active control treatment (electromyogram biofeedback)
Number of subjects: 103
Study 34416347 — intervention group
Group type: EXPERIMENTAL
Intervention: SCP-NF
Number of subjects: 103
Study 34416347 — intervention group
Group type: COMPARATOR
Intervention: SCP-NF and Semi-active control treatment
Number of subjects: 103
Study 34586963 — intervention group
Group type: EXPERIMENTAL
Intervention: Total calcium intake (fourth vs. first quartiles in the DHQ cohort)
Number of subjects: 101622
Study 34586963 — intervention group
Group type: EXPERIMENTAL
Intervention: Total magnesium intake (fourth vs. first quartiles in the DQX cohort)
Number of subjects: 101622
Study 34586963 — intervention group
Group type: EXPERIMENTAL
Intervention: Total phosphorus intake
Number of subjects: 101622
Study 33712986 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual risk reduction intervention incorporating alcohol risk reduction content (GPI + GMET)
Number of subjects: 269
Study 33712986 — intervention group
Group type: COMPARATOR
Intervention: Information-only control (GINFO)
Number of subjects: 269
Study 32003294 — intervention group
Group type: COMPARATOR
Intervention: Heavy metal pollution (Pb and Zn) in soil samples from Mitrovica and Obiliqi regions
Number of subjects: 2
Study 32003294 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-D enzyme response as a biomarker
Number of subjects: 2
Study 32003294 — intervention group
Group type: EXPERIMENTAL
Intervention: Total chlorophyll content in leaves of onion plants
Number of subjects: 2
Study 32003294 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA content in leaves of onion plants
Number of subjects: 2
Study 35708431 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP (triple antibiotic paste)
Number of subjects: 180
Study 35708431 — intervention group
Group type: EXPERIMENTAL
Intervention: UI (ultrasonic activation)
Number of subjects: 180
Study 33619943 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon Ankle Seven® (CAFO)
Number of subjects: 10
Study 33619943 — intervention group
Group type: COMPARATOR
Intervention: Hinged ankle-foot orthoses (HAFO)
Number of subjects: 10
Study 32895432 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised networks preserving community structure
Number of subjects: 0
Study 32895432 — intervention group
Group type: COMPARATOR
Intervention: Empirical networks
Number of subjects: 0
Study 34851731 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity best practices
Number of subjects: 127
Study 34851731 — intervention group
Group type: EXPERIMENTAL
Intervention: Leading a planned PA class more than once a week
Number of subjects: 127
Study 34851731 — intervention group
Group type: EXPERIMENTAL
Intervention: No screen time during meal or snack
Number of subjects: 127
Study 34851731 — intervention group
Group type: EXPERIMENTAL
Intervention: Not modeling sedentary behavior
Number of subjects: 127
Study 34851731 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing families with information about children's screen time
Number of subjects: 127
Study 34851731 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing children with >60 minutes of outdoor play daily
Number of subjects: 127
Study 34851731 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing children with >45 minutes of adult-led physical activity each day
Number of subjects: 127
Study 34851731 — intervention group
Group type: EXPERIMENTAL
Intervention: Participating in outdoor physical activity with children
Number of subjects: 127
Study 34851731 — intervention group
Group type: EXPERIMENTAL
Intervention: Participating in indoor physical activity with children
Number of subjects: 127
Study 34851731 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompting and praising children for being active
Number of subjects: 127
Study 34851731 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking with children informally about the importance of physical activity
Number of subjects: 127
Study 33790420 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use after ADT
Number of subjects: 4428
Study 33790420 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use defined with a one‐year lag
Number of subjects: 4428
Study 33790420 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use before ADT initiation
Number of subjects: 4428
Study 33790420 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use in the first year on ADT
Number of subjects: 4428
Study 34953603 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment of 77 Gy to the entire prostate in 35 fractions
Number of subjects: 571
Study 34953603 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional boost to the macroscopic tumor of up to 95 Gy during EBRT
Number of subjects: 571
Study 32356753 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable sensors (IMU and GPS data)
Number of subjects: 31
Study 32356753 — intervention group
Group type: COMPARATOR
Intervention: Lab assessment of self-selected walking speed
Number of subjects: 31
Study 34408212 — intervention group
Group type: EXPERIMENTAL
Intervention: Grazing at canopy heights of 12/7 cm, 20/12 cm, 28/17 cm, and 36/22 cm with beef heifers from October 2015 to October 2017.
Number of subjects: 87
Study 34408212 — intervention group
Group type: EXPERIMENTAL
Intervention: Grazing intensity (various canopy heights).
Number of subjects: 87
Study 32730797 — intervention group
Group type: COMPARATOR
Intervention: VOL + US
Number of subjects: 51
Study 32730797 — intervention group
Group type: COMPARATOR
Intervention: VOL
Number of subjects: 51
Study 32730797 — intervention group
Group type: EXPERIMENTAL
Intervention: VOL and VOL + US
Number of subjects: 51
Study 34099307 — intervention group
Group type: EXPERIMENTAL
Intervention: GENE arm (pharmacogenetic testing results available at baseline, n = 84)
Number of subjects: 176
Study 34099307 — intervention group
Group type: COMPARATOR
Intervention: TAU arm (treatment-as-usual, testing results not available until 8-week visit, n = 92)
Number of subjects: 176
Study 34330539 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced Training in Laparoscopic Suturing
Number of subjects: 39
Study 34330539 — intervention group
Group type: COMPARATOR
Intervention: Fundamentals of Laparoscopic Surgery
Number of subjects: 39
Study 35907262 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS (10 Hz)
Number of subjects: 43
Study 35907262 — intervention group
Group type: EXPERIMENTAL
Intervention: Active WMT
Number of subjects: 43
Study 35907262 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS + Active WMT
Number of subjects: 43
Study 35907262 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 43
Study 35907262 — intervention group
Group type: COMPARATOR
Intervention: Sham WMT
Number of subjects: 43
Study 34616363 — intervention group
Group type: EXPERIMENTAL
Intervention: DROI-FET
Number of subjects: 307
Study 34616363 — intervention group
Group type: COMPARATOR
Intervention: mNC-FET
Number of subjects: 307
Study 34469646 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil + glucocorticoid
Number of subjects: 120
Study 34469646 — intervention group
Group type: COMPARATOR
Intervention: Glucocorticoid only (standard care)
Number of subjects: 120
Study 32842225 — intervention group
Group type: EXPERIMENTAL
Intervention: H-UPPP combined with Eco-TBR
Number of subjects: 60
Study 32842225 — intervention group
Group type: COMPARATOR
Intervention: Simple H-UPPP (Control)
Number of subjects: 60
Study 35961356 — intervention group
Group type: EXPERIMENTAL
Intervention: Typhoid conjugate vaccine (TCV)
Number of subjects: 631
Study 35961356 — intervention group
Group type: COMPARATOR
Intervention: Meningococcal serogroup A conjugate vaccine (MCV-A)
Number of subjects: 631
Study 35961356 — intervention group
Group type: EXPERIMENTAL
Intervention: TCV
Number of subjects: 631
Study 35961356 — intervention group
Group type: COMPARATOR
Intervention: MCV-A
Number of subjects: 631
Study 32166551 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic resection (ER)
Number of subjects: 391
Study 32166551 — intervention group
Group type: COMPARATOR
Intervention: Surgical resection (SR)
Number of subjects: 391
Study 32166551 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic surgery (hypothetical comparison)
Number of subjects: 391
Study 35285531 — intervention group
Group type: COMPARATOR
Intervention: paper CARAT
Number of subjects: 31
Study 35285531 — intervention group
Group type: COMPARATOR
Intervention: online CARAT
Number of subjects: 31
Study 35285531 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 31
Study 32333539 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-snake moxibustion
Number of subjects: 90
Study 32333539 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 90
Study 32333539 — intervention group
Group type: COMPARATOR
Intervention: Medication (Diclofenac Sodium and Mecobalamine)
Number of subjects: 90
Study 35551290 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg d−1 with closed-loop therapy
Number of subjects: 27
Study 35551290 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg d−1 with sensor-augmented pump (SAP) therapy
Number of subjects: 27
Study 35551290 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop therapy plus empagliflozin
Number of subjects: 27
Study 35551290 — intervention group
Group type: COMPARATOR
Intervention: Placebo with closed-loop therapy
Number of subjects: 27
Study 35551290 — intervention group
Group type: COMPARATOR
Intervention: Placebo with SAP therapy
Number of subjects: 27
Study 33914770 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition readiness assessment
Number of subjects: 786
Study 33914770 — intervention group
Group type: EXPERIMENTAL
Intervention: Trusting peer educators for HIV treatment
Number of subjects: 786
Study 33914770 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving counselling on transition to adult services
Number of subjects: 786
Study 33914770 — intervention group
Group type: EXPERIMENTAL
Intervention: Visiting an adult clinic to prepare for transition
Number of subjects: 786
Study 33914770 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with the transition process
Number of subjects: 786
Study 36027483 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib
Number of subjects: 102
Study 36027483 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine/Cisplatin (Chemotherapy)
Number of subjects: 102
Study 33579322 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-domain NPCCSS
Number of subjects: 49
Study 33964483 — intervention group
Group type: EXPERIMENTAL
Intervention: Short wavelength light for 8 weeks
Number of subjects: 3
Study 33964483 — intervention group
Group type: EXPERIMENTAL
Intervention: Long wavelength light for 8 weeks
Number of subjects: 3
Study 33964483 — intervention group
Group type: COMPARATOR
Intervention: White light for 8 weeks
Number of subjects: 3
Study 33105928 — intervention group
Group type: EXPERIMENTAL
Intervention: Yimitasvir phosphate capsules with sofosbuvir tablets
Number of subjects: 84
Study 33105928 — intervention group
Group type: EXPERIMENTAL
Intervention: Yimitasvir phosphate capsules with omeprazole magnesium enteric-coated tablets
Number of subjects: 84
Study 33105928 — intervention group
Group type: EXPERIMENTAL
Intervention: Yimitasvir phosphate capsules with rosuvastatin calcium tablets
Number of subjects: 84
Study 35294067 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin resistance (IR) defined by HOMA-IR >2.5
Number of subjects: 84
Study 35294067 — intervention group
Group type: COMPARATOR
Intervention: Non-insulin resistance (non-IR)
Number of subjects: 84
Study 32557001 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser therapy with 50 units of BTX-A solution applied topically post-operatively
Number of subjects: 3
Study 32557001 — intervention group
Group type: COMPARATOR
Intervention: Untreated control (other palm)
Number of subjects: 3
Study 32942294 — intervention group
Group type: EXPERIMENTAL
Intervention: Implemental mindset
Number of subjects: 64
Study 32942294 — intervention group
Group type: COMPARATOR
Intervention: Deliberative mindset
Number of subjects: 64
Study 32942294 — intervention group
Group type: EXPERIMENTAL
Intervention: Both mindsets
Number of subjects: 64
Study 35805348 — intervention group
Group type: EXPERIMENTAL
Intervention: Group EMDR intervention for three weeks
Number of subjects: 27
Study 35805348 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 27
Study 86263812 — intervention group
Group type: EXPERIMENTAL
Intervention: Branched chain amino acids (0.25 g/kg/day)
Number of subjects: 22
Study 86263812 — intervention group
Group type: COMPARATOR
Intervention: Casein (0.25 g/kg/day)
Number of subjects: 22
Study 35908387 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% body mass (Group 2)
Number of subjects: 30
Study 35908387 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% body mass (Group 3)
Number of subjects: 30
Study 35908387 — intervention group
Group type: COMPARATOR
Intervention: No load (Group 1)
Number of subjects: 30
Study 34639688 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-sampling devices (FLOQSwabs, Evalyn Brush, Colli-Pee FV-5000)
Number of subjects: 65
Study 35848042 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal stimulations (MMS) for 30 minutes per session, five days per week until discharge
Number of subjects: 60
Study 35848042 — intervention group
Group type: COMPARATOR
Intervention: Regular lifesaving care from the NICU
Number of subjects: 60
Study 33519155 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 888
Study 33012658 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil-based contrast
Number of subjects: 1107
Study 33012658 — intervention group
Group type: COMPARATOR
Intervention: Water-based contrast
Number of subjects: 1107
Study 34814156 — intervention group
Group type: EXPERIMENTAL
Intervention: cPFM‐T in supine position (SUG)
Number of subjects: 55
Study 34814156 — intervention group
Group type: EXPERIMENTAL
Intervention: cPFM‐T in sitting position (SIG)
Number of subjects: 55
Study 34814156 — intervention group
Group type: COMPARATOR
Intervention: Control group (COG)
Number of subjects: 55
Study 34314235 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm-cycle ergometer training (ACET)
Number of subjects: 46
Study 34314235 — intervention group
Group type: EXPERIMENTAL
Intervention: Body-weight-supported treadmill training (BWSTT)
Number of subjects: 46
Study 34314235 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 46
Study 32317241 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning-based treatment planning system (PIPA system)
Number of subjects: 41
Study 32317241 — intervention group
Group type: COMPARATOR
Intervention: Conventional, manual treatment planning technique
Number of subjects: 41
Study 35474582 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual 300 IR HDM tablets
Number of subjects: 100
Study 35474582 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 100
Study 33055145 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase (thrombolysis)
Number of subjects: 2916
Study 36101998 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week community-based exercise programme (FitSkills)
Number of subjects: 20
Study 34035435 — intervention group
Group type: EXPERIMENTAL
Intervention: TARGIT‐IORT
Number of subjects: 2298
Study 34035435 — intervention group
Group type: COMPARATOR
Intervention: TARGIT‐IORT plus EBRT
Number of subjects: 2298
Study 34035435 — intervention group
Group type: COMPARATOR
Intervention: EBRT
Number of subjects: 2298
Study 33444385 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian prediction models with elicited expert opinion
Number of subjects: 118
Study 33444385 — intervention group
Group type: COMPARATOR
Intervention: Original frequentist approach
Number of subjects: 118
Study 33444385 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian models with elicited expert opinion
Number of subjects: 118
Study 34637064 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding support intervention
Number of subjects: 13
Study 33617653 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethersulfone (PES) membranes
Number of subjects: 8
Study 33617653 — intervention group
Group type: COMPARATOR
Intervention: Ethylene-vinyl alcohol copolymer (EVAL) membranes
Number of subjects: 8
Study 33617653 — intervention group
Group type: COMPARATOR
Intervention: EVAL membranes
Number of subjects: 8
Study 33617653 — intervention group
Group type: EXPERIMENTAL
Intervention: PES membranes
Number of subjects: 8
Study 33617653 — intervention group
Group type: EXPERIMENTAL
Intervention: Both membrane types
Number of subjects: 8
Study 33617653 — intervention group
Group type: EXPERIMENTAL
Intervention: Both membrane sets
Number of subjects: 8
Study 32202203 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training augmented by virtual reality (TT + VR)
Number of subjects: 121
Study 32202203 — intervention group
Group type: COMPARATOR
Intervention: Usual treadmill walking (TT)
Number of subjects: 121
Study 32202203 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training (TT + VR and TT)
Number of subjects: 121
Study 36134707 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model developed using clinical and drug-related variables from training data set.
Number of subjects: 1446
Study 34283733 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer teaching series (RxReady)
Number of subjects: 98
Study 32700954 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral Activation and Motivational Interviewing intervention (5 sessions)
Number of subjects: 9
Study 32700954 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-post assessment of depression symptoms and family-related outcomes
Number of subjects: 9
Study 35235635 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid PRF
Number of subjects: 15
Study 35235635 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study 33795569 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-pass pulsed-dye laser (DPL) with long pulse duration (20 m/s) followed by short pulse duration (1.5 m/s)
Number of subjects: 24
Study 33795569 — intervention group
Group type: COMPARATOR
Intervention: Single-pass pulsed-dye laser (SPL) at 1.5 m/s
Number of subjects: 24
Study 33795569 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-pass pulsed-dye laser (DPL)
Number of subjects: 24
Study 33795569 — intervention group
Group type: COMPARATOR
Intervention: Single-pass pulsed-dye laser (SPL)
Number of subjects: 24
Study 32941336 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatonometry
Number of subjects: 20
Study 32941336 — intervention group
Group type: EXPERIMENTAL
Intervention: Transpalpebral tonometry
Number of subjects: 20
Study 32941336 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumentation used for IOP measurement
Number of subjects: 20
Study 35657826 — intervention group
Group type: EXPERIMENTAL
Intervention: lenacapavir as PrEP
Number of subjects: 0
Study 34769642 — intervention group
Group type: EXPERIMENTAL
Intervention: Posters as a teaching tool
Number of subjects: 293
Study 34769642 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-practice hand contamination
Number of subjects: 293
Study 32519599 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular low-dose sustained-release morphine (8-32 mg/24 h)
Number of subjects: 22
Study 35294582 — intervention group
Group type: EXPERIMENTAL
Intervention: Ureteral stent crossing the bladder midline
Number of subjects: 113
Study 35294582 — intervention group
Group type: COMPARATOR
Intervention: Ureteral stent not crossing the bladder midline
Number of subjects: 113
Study 32009828 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailor‐made standard rehabilitation (TMSR) plus immersive VR device
Number of subjects: 262